Jingsong Mao

971 total citations
45 papers, 732 citations indexed

About

Jingsong Mao is a scholar working on Biomedical Engineering, Hepatology and Surgery. According to data from OpenAlex, Jingsong Mao has authored 45 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Biomedical Engineering, 14 papers in Hepatology and 10 papers in Surgery. Recurrent topics in Jingsong Mao's work include Nanoplatforms for cancer theranostics (17 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers) and Nanoparticle-Based Drug Delivery (5 papers). Jingsong Mao is often cited by papers focused on Nanoplatforms for cancer theranostics (17 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers) and Nanoparticle-Based Drug Delivery (5 papers). Jingsong Mao collaborates with scholars based in China, Singapore and Macao. Jingsong Mao's co-authors include Gang Liu, Hongwei Cheng, Chengchao Chu, Yang Zhang, Hu Chen, Shuang Bai, Zhixiang Lu, Dengfeng Li, Pan He and Dazhuang Xu and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Jingsong Mao

42 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingsong Mao China 17 456 145 130 126 124 45 732
Shu-Guang Zheng China 15 436 1.0× 157 1.1× 126 1.0× 181 1.4× 119 1.0× 24 837
Guofeng Zhou China 15 259 0.6× 216 1.5× 167 1.3× 166 1.3× 126 1.0× 48 786
Guobin Hong China 17 326 0.7× 81 0.6× 118 0.9× 167 1.3× 90 0.7× 35 675
Akinaga Sonoda Japan 14 194 0.4× 98 0.7× 126 1.0× 93 0.7× 184 1.5× 65 669
Chihua Fang China 9 464 1.0× 47 0.3× 197 1.5× 110 0.9× 95 0.8× 40 653
Pan He China 11 827 1.8× 137 0.9× 443 3.4× 106 0.8× 214 1.7× 20 1.2k
Lei Xia China 15 307 0.7× 52 0.4× 166 1.3× 100 0.8× 125 1.0× 35 703
Jinshun Xu China 13 387 0.8× 46 0.3× 79 0.6× 188 1.5× 66 0.5× 39 574
Dennis Doleschel Germany 11 257 0.6× 101 0.7× 71 0.5× 62 0.5× 58 0.5× 17 678
Andrew S. Mikhail United States 17 556 1.2× 165 1.1× 114 0.9× 520 4.1× 111 0.9× 46 1.2k

Countries citing papers authored by Jingsong Mao

Since Specialization
Citations

This map shows the geographic impact of Jingsong Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingsong Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingsong Mao more than expected).

Fields of papers citing papers by Jingsong Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingsong Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingsong Mao. The network helps show where Jingsong Mao may publish in the future.

Co-authorship network of co-authors of Jingsong Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Jingsong Mao. A scholar is included among the top collaborators of Jingsong Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingsong Mao. Jingsong Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Hui, Hu Chen, Zhenjie Li, et al.. (2025). Self-assembling chemodrug fiber-hydrogel for transarterial chemoembolization and radiotherapy-enhanced antitumor immunity. Journal of Controlled Release. 380. 1–16. 9 indexed citations
2.
Chen, Hu, Yongfu Xiong, Yesen Li, et al.. (2025). A preclinical and first-in-human study of superstable homogeneous radiolipiodol for revolutionizing interventional diagnosis and treatment of hepatocellular carcinoma. Acta Pharmaceutica Sinica B. 15(10). 5022–5035. 4 indexed citations
3.
Wu, Huiling, Guangxing Wang, Kun Wang, et al.. (2024). Neuroprotective effects of anti-TRAIL-ICG nanoagent and its multimodal imaging evaluation in cerebral ischemia-reperfusion injury. Materials Today Bio. 26. 101094–101094. 4 indexed citations
4.
Li, Jiwei, Jing Wu, Jingsong Mao, et al.. (2024). A transcriptome-based risk model in sepsis enables prognostic prediction and drug repositioning. iScience. 27(12). 111277–111277. 1 indexed citations
6.
Wang, Mingdong, Yali Zheng, Liang Zhang, et al.. (2024). Hepatotoxicity of nanomaterials: From mechanism to therapeutic strategy. Nanotechnology Reviews. 13(1). 1 indexed citations
7.
Yang, Jiemin, et al.. (2024). Hepatic infarction occurred after 125I particle stent treatment for hepatocellular carcinoma with portal vein tumor thrombus: A case report. Journal of Cancer Research and Clinical Oncology. 150(6). 308–308.
8.
Liu, Hui, Hu Chen, Zhenjie Li, et al.. (2024). Rhein‐based Pickering emulsion for hepatocellular carcinoma: Shaping the metabolic signaling and immunoactivation in transarterial chemoembolization. SHILAP Revista de lepidopterología. 5(4). 24 indexed citations
9.
Chen, Zhiwen, Guangshun Wang, Yang Yang, et al.. (2023). Fabrication of flexible organic field effect transistors with high carrier mobility via sheath gas-assisted direct writing Poly(3-hexylthiophene) solution. Organic Electronics. 119. 106813–106813. 1 indexed citations
10.
Xu, Ling, Hu Chen, Pan He, et al.. (2023). 3D Hollow Porous Radio‐Granular Hydrogels for SPECT Imaging‐Guided Cancer Intravascular Brachytherapy. Advanced Functional Materials. 33(22). 7 indexed citations
11.
Xu, Xiao, Hu Chen, Yangjie Wang, et al.. (2023). Engineering Radioactive Microspheres for Intra‐Arterial Brachytherapy Using Radiation‐Induced Graft Polymerization. Advanced Functional Materials. 33(50). 12 indexed citations
13.
Huang, Xiaoxue, et al.. (2022). [18F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[18F]FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 50(4). 1205–1215. 25 indexed citations
14.
Zhang, Yunrui, Junwei Li, Chunlei Liu, et al.. (2022). Development of a multi-scene universal multiple wavelet-FFT algorithm (MW-FFTA) for denoising motion artifacts in OCT-angiography in vivo imaging. Optics Express. 30(20). 35854–35854. 3 indexed citations
15.
Li, Zhenjie, Hongwei Cheng, Jingsong Mao, & Gang Liu. (2022). Conversion therapy of intermediate and advanced hepatocellular carcinoma using superstable homogeneous iodinated formulation technology. Science China Life Sciences. 65(10). 2114–2117. 14 indexed citations
16.
Zhao, Yang, et al.. (2022). Remote vascular interventional surgery robotics: a literature review. Quantitative Imaging in Medicine and Surgery. 12(4). 2552–2574. 36 indexed citations
17.
Huang, Doudou, Guangxing Wang, Jingsong Mao, et al.. (2021). Intravital Whole‐Process Monitoring Thermo‐Chemotherapy Via 2D Silicon Nanoplatform: A Macro Guidance and Long‐Term Microscopic Precise Imaging Strategy. Advanced Science. 8(16). e2101242–e2101242. 14 indexed citations
19.
Zhang, Yang, Hongwei Cheng, Hu Chen, et al.. (2021). A pure nanoICG-based homogeneous lipiodol formulation: toward precise surgical navigation of primary liver cancer after long-term transcatheter arterial embolization. European Journal of Nuclear Medicine and Molecular Imaging. 49(8). 2605–2617. 39 indexed citations
20.
Fu, Changhui, Longfei Tan, Tianlong Liu, et al.. (2017). Imaging-guided synergetic therapy of orthotopic transplantation tumor by superselectively arterial administration of microwave-induced microcapsules. Biomaterials. 133. 144–153. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026